Key facts
- This page summarizes Halley E. Gilbert's Form 5 filing for NEOGENOMICS INC (NEO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 08 Feb 2022, 18:12.
Halley E. Gilbert - 31 Dec 2021 Form 5 Insider Report for NEOGENOMICS INC (NEO)
- Reporting relationship
- Chief Legal Officer
- Issuer ticker
- NEO
- Reported as of
- 31 Dec 2021
- Net transaction value
- +$5,540
- SEC form
- 5
- Accepted by SEC
- 08 Feb 2022, 18:12:44 UTC
- Prior SEC filing
- 30 Dec 2021
- Next SEC filing
- 03 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Halley E. Gilbert
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Halley E. Gilbert filed Form 5 for NEOGENOMICS INC (NEO) on 08 Feb 2022.
Change
- Previous filing in this sequence was filed on 30 Dec 2021.
- Current net transaction value: +$5,540.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEO
transaction
Common Stock
Small acquisition under Rule 16a-6
- Transaction value
- $5,540
- Shares
- +177
- Change %
- +0.17%
- Price
- $31.30
- Shares after
- 105,263
- Date
- 31 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 63,331
- Date
- 31 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 63,331
- Exercise price
- $42.21
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2021. The shares were acquired in transactions exempt from Section 16b-3.
Footnote F2
On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date.